The Effect of Chronic Disease Management Program on the Risk of Complications in Patients With Hypertension in Korea

Sang Ah Lee1, Hyeki Park2,3, Woorim Kim4

  • 1BigData Strategy Department, National Health Insurance Service, Wonju, Korea.

Insights

Participating in a chronic disease management program reduced the risk of hypertension complications like heart attack and stroke. Increased program enrollment may lead to better patient outcomes and lower healthcare costs.

Area of Science:

  • Public Health
  • Health Services Research
  • Cardiovascular Medicine

Background:

  • A chronic disease management program was initiated to decrease out-of-pocket expenses for patients with chronic conditions requiring regular clinic visits.
  • This program incentivizes patients to attend the same clinic for managing hypertension or diabetes by reducing consultation fees.

Purpose of the Study:

  • To evaluate the association between enrollment in a chronic disease management program and the incidence of major cardiovascular and renal complications in hypertensive patients.
  • To analyze the impact of reduced out-of-pocket costs on patient adherence and subsequent health outcomes.

Main Methods:

  • Utilized nationwide claims data from the National Health Insurance Service (2011-2018).
  • Included patients newly diagnosed with hypertension between 2012 and 2014.
  • Employed Cox proportional hazards models to assess the risk of acute myocardial infarction (MI), stroke, chronic kidney disease (CKD), and heart failure (HF) in relation to program participation.

Main Results:

  • Out of 827,577 participants, 12.6% enrolled in the chronic disease management program.
  • Program participants exhibited significantly lower hazard ratios for all studied complications compared to non-participants.
  • Specific hazard ratios included MI (0.75), stroke (0.75), CKD (0.90), and heart failure (0.56).

Conclusions:

  • Participation in the chronic disease management program is associated with a reduced likelihood of developing major complications in patients with hypertension.
  • Findings suggest that increasing enrollment in such programs could improve health outcomes and reduce healthcare expenditures for chronic disease management.
  • The program's financial incentives appear effective in encouraging consistent care, potentially leading to better disease control.
Abstract

Related Concept Videos

Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
50
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
35
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
76
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
30
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
35
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
956